Biosurgical Agents | Market Insights | US | 2023
The COVID-19 pandemic had a negative impact on the US biosurgical agent market. However, recovery of the deferred procedures and procedure volume growth will drive modest growth in the market over the forecast period. Moreover, the market will be driven by rising awareness of the clinical benefits of biosurgical agents in surgical procedures and product approvals for expanded indications.
This Medtech 360 Report provides comprehensive data and analysis on the state of the market for biosurgical agents in the US from 2019 through 2031.